{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:21:00Z","timestamp":1760487660746,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2912,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.bbadis.2005.05.002","type":"journal-article","created":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T11:55:01Z","timestamp":1118404501000},"page":"300-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lysosomal leukocyte \u03b2-d-glucuronidase during enzyme replacement therapy in Fabry disease"],"prefix":"10.1016","volume":"1741","author":[{"given":"Giancarlo","family":"Goi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Massaccesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro P.","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia J.","family":"Baquero Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Tettamanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto B.","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2005.05.002_bib1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2005.05.002_bib2","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1016\/S0021-9258(18)51888-3","article-title":"Fabry's disease: classification as a sphingolipidosis and characterization of a novel glycolipid","volume":"238","author":"Sweeley","year":"1963","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2005.05.002_bib3","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson\u2013Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbadis.2005.05.002_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2004.01.011","article-title":"Fabry disease: reduced activities of respiratory chain enzymes with decreased levels of energy-rich phosphate in fibroblasts","volume":"82","author":"L\u00fccke","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2005.05.002_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbadis.2005.05.002_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1073\/pnas.97.1.365","article-title":"Infusion of \u03b1-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease","volume":"97","author":"Schiffmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2005.05.002_bib7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.CIR.0000091253.71282.04","article-title":"Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study","volume":"108","author":"Weidemann","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2005.05.002_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human \u03b1-galactosidase A replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2005.05.002_bib9","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffman","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2005.05.002_bib10","first-page":"954","article-title":"Enzyme replacement and enhancement therapies: lessons from lysosomal disorders","volume":"3","author":"Desnick","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2005.05.002_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1651-2227.2002.tb03112.x","article-title":"Endothelial markers and homocysteine in patients with classic Fabry disease","volume":"439","author":"Demuth","year":"2002","journal-title":"Acta Paediatr., Suppl."},{"key":"10.1016\/j.bbadis.2005.05.002_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T","article-title":"Profile of endothelial and leukocyte activation in Fabry disease. Patients","volume":"47","author":"DeGraba","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2005.05.002_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0009-8981(80)90339-3","article-title":"Enzymes of lysosomal origin in human plasma and serum: assay conditions and parameters influencing the assay","volume":"108","author":"Lombardo","year":"1980","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbadis.2005.05.002_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0009-8981(81)90148-0","article-title":"Influence of age and sex on five human plasma lysosomal enzymes assayed by automated procedures","volume":"113","author":"Lombardo","year":"1981","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbadis.2005.05.002_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0009-8981(84)90313-9","article-title":"Lysosomal glycohydrolases in normal T and non-T peripheral lymphocytes","volume":"137","author":"Lombardo","year":"1984","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbadis.2005.05.002_bib16","first-page":"249","article-title":"Levels of some lysosomal activities in newborns","volume":"5","author":"Goi","year":"1984","journal-title":"Perspect. Inherited. Metab. Dis."},{"key":"10.1016\/j.bbadis.2005.05.002_bib17","first-page":"93","article-title":"Chronobiological study of several enzymes of lysosomal origin in human plasma","volume":"16","author":"Goi","year":"1989","journal-title":"Chronobiologia"},{"key":"10.1016\/j.bbadis.2005.05.002_bib18","first-page":"595","article-title":"Preparation of a stable liquid material for calibration and quality control for lysosomal enzymes in plasma. Assay of enzymes of lysosomal origin in plasma: I.","volume":"30","author":"Goi","year":"1992","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.bbadis.2005.05.002_bib19","first-page":"737","article-title":"Automated fluorimetric assay procedure for glycohydrolases using a routine centrifugal analyzer assay of enzymes of lysosomal origin in plasma: II.","volume":"33","author":"Goi","year":"1995","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.bbadis.2005.05.002_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.155.3758.86","article-title":"Diagnosis of Gaucher's disease and Nieman\u2013Pick's disease with small samples of venous blood","volume":"155","author":"Kampine","year":"1967","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2005.05.002_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0009-8981(80)90339-3","article-title":"Enzymes of lysosomal origin in human plasma and serum: assay conditions and parameters influencing the assay","volume":"108","author":"Lombardo","year":"1980","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbadis.2005.05.002_bib22","first-page":"45","article-title":"Lipid storage diseases: biochemical diagnosis","volume":"13","author":"Tettamanti","year":"1977","journal-title":"Biochem. Exp. Biol."},{"key":"10.1016\/j.bbadis.2005.05.002_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2005.05.002_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0962-8924(03)00005-9","article-title":"At the acidic edge: emerging functions for lysosomal protein","volume":"13","author":"Eskelinen","year":"2003","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbadis.2005.05.002_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/bies.1048","article-title":"The molecular machinery for lysosome biogenesis","volume":"23","author":"Mullins","year":"2001","journal-title":"BioEssays"},{"key":"10.1016\/j.bbadis.2005.05.002_bib26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.cb.05.110189.002411","article-title":"The biogenesis of lysosomes","volume":"5","author":"Kornfeld","year":"1989","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1016\/j.bbadis.2005.05.002_bib27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/bst0180367","article-title":"Lysosomal enzyme targeting","volume":"18","author":"Kornfeld","year":"1990","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbadis.2005.05.002_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0304-4157(95)00004-B","article-title":"Mannose 6-phosphate receptors in sorting and transport of lysosomal enzymes","volume":"1241","author":"Hile-Rehfield","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2005.05.002_bib29","first-page":"954","article-title":"Enzyme replacement and enhancement therapies: lessons from lysosomal disorders","volume":"3","author":"Desnick","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2005.05.002_bib30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbadis.2005.05.002_bib31","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk","volume":"113","author":"Van den Hout","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbadis.2005.05.002_bib32","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1096\/fj.00-0014com","article-title":"Infusion of recombinant human acid sphingomyelinase into Niemann\u2013Pick disease mice leads to visceral, but not neurological correction of the pathophysiology","volume":"14","author":"Miranda","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2005.05.002_bib33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2005.05.002_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1651-2227.2002.tb03118.x","article-title":"Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report","volume":"91","author":"Muenzer","year":"2002","journal-title":"Acta Paediatrica"},{"key":"10.1016\/j.bbadis.2005.05.002_bib35","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","article-title":"Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux\u2013Lamy syndrome)","volume":"144","author":"Harmatz","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbadis.2005.05.002_bib36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/4801","article-title":"Accelerated transport and maturation of lysosomal \u03b1-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor","volume":"5","author":"Fan","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2005.05.002_bib37","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1046\/j.1432-1327.2000.01457.x","article-title":"In vitro inhibition and intracellular enhancement of lysosomal \u03b1-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives","volume":"267","author":"Asano","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbadis.2005.05.002_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJM200107053450104","article-title":"Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy","volume":"345","author":"Frustaci","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2005.05.002_bib39","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1098\/rstb.2003.1277","article-title":"Gene therapy: prospects for glycolipid storage diseases","volume":"358","author":"Gieselmann","year":"2003","journal-title":"Philos. Trans. R. Soc. London, B"},{"key":"10.1016\/j.bbadis.2005.05.002_bib40","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1073\/pnas.0537900100","article-title":"Long-term correction of globotriaosylceramide storage in Fabry mice by recombinant adeno-associated virus-mediated gene transfer","volume":"100","author":"Park","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2005.05.002_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/422366","article-title":"Long-term safety and efficacy of enzyme replacement therapy for Fabry disease","volume":"75","author":"Wilcox","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2005.05.002_bib42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","article-title":"The Mainz severity score index: a new instrument for quantifying the Anderson\u2013Fabry disease phenotype, and the response of patients to enzyme replacement therapy","volume":"65","author":"Whybra","year":"2004","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bbadis.2005.05.002_bib43","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3733","article-title":"\u03b1-Galactosidase a deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.bbadis.2005.05.002_bib44","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/meta.2000.9507","article-title":"Plasma glycohydrolase levels in patients with type 1 diabetes at onset and in subjects undergoing an intravenous glucose tolerance test","volume":"49","author":"Goi","year":"2000","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.bbadis.2005.05.002_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0009-8981(97)06515-7","article-title":"Effects of lead and manganese on the release of lysosomal enzymes in vitro and in vivo","volume":"26","author":"Bairati","year":"1997","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbadis.2005.05.002_bib46","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1023\/A:1025904132569","article-title":"Towards quality assurance in the determination of lysosomal enzymes: a two-centre study","volume":"26","author":"Lukacs","year":"2003","journal-title":"J. Inherited Metab. Dis."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443905000839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443905000839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:35:54Z","timestamp":1760416554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443905000839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0925443905000839"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2005.05.002","relation":{},"ISSN":["0925-4439"],"issn-type":[{"type":"print","value":"0925-4439"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysosomal leukocyte \u03b2-d-glucuronidase during enzyme replacement therapy in Fabry disease","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2005.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}